Kirkitadze MD - Search Results

1

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.

Kirkitadze MD, Bitan G, Teplow DB. Kirkitadze MD, et al. J Neurosci Res. 2002 Sep 1;69(5):567-77. doi: 10.1002/jnr.10328. J Neurosci Res. 2002. PMID: 12210822 Review.

2

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. Bitan G, et al. Among authors: kirkitadze md. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):330-5. doi: 10.1073/pnas.222681699. Epub 2002 Dec 27. Proc Natl Acad Sci U S A. 2003. PMID: 12506200 Free PMC article.

3

Structure determination of micelle-like intermediates in amyloid beta -protein fibril assembly by using small angle neutron scattering.

Yong W, Lomakin A, Kirkitadze MD, Teplow DB, Chen SH, Benedek GB. Yong W, et al. Among authors: kirkitadze md. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):150-4. doi: 10.1073/pnas.012584899. Epub 2001 Dec 26. Proc Natl Acad Sci U S A. 2002. PMID: 11756677 Free PMC article.

4

Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

Kirkitadze MD, Condron MM, Teplow DB. Kirkitadze MD, et al. J Mol Biol. 2001 Oct 5;312(5):1103-19. doi: 10.1006/jmbi.2001.4970. J Mol Biol. 2001. PMID: 11580253

5

A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner.

Mousseau DD, Chapelsky S, De Crescenzo G, Kirkitadze MD, Magoon J, Inoue S, Teplow DB, O'Connor-McCourt MD. Mousseau DD, et al. Among authors: kirkitadze md. J Biol Chem. 2003 Oct 3;278(40):38715-22. doi: 10.1074/jbc.M304080200. Epub 2003 Jul 16. J Biol Chem. 2003. PMID: 12867422 Free article.

6

Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.

Kirkitadze MD, Kowalska A. Kirkitadze MD, et al. Acta Biochim Pol. 2005;52(2):417-23. Epub 2005 May 31. Acta Biochim Pol. 2005. PMID: 15933761 Review.

7

Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.

Li L, Kirkitadze M, Bhandal K, Roque C, Yang E, Carpick B, Rahman N. Li L, et al. Curr Pharm Biotechnol. 2017 Nov 10;18(8):638-647. doi: 10.2174/1389201018666170914123305. Curr Pharm Biotechnol. 2017. PMID: 28914197

8

Tuberculosis vaccine candidate: Characterization of H4-IC31 formulation and H4 antigen conformation.

Deshmukh SS, Magcalas FW, Kalbfleisch KN, Carpick BW, Kirkitadze MD. Deshmukh SS, et al. Among authors: kirkitadze md. J Pharm Biomed Anal. 2018 Aug 5;157:235-243. doi: 10.1016/j.jpba.2018.05.048. Epub 2018 May 31. J Pharm Biomed Anal. 2018. PMID: 29866391 Free article.

9

²⁷Al and ³¹P NMR spectroscopy method development to quantify aluminum phosphate in adjuvanted vaccine formulations.

Khatun R, Hunter HN, Sheng Y, Carpick BW, Kirkitadze MD. Khatun R, et al. Among authors: kirkitadze md. J Pharm Biomed Anal. 2018 Sep 10;159:166-172. doi: 10.1016/j.jpba.2018.06.025. Epub 2018 Jun 21. J Pharm Biomed Anal. 2018. PMID: 29990882 Free article.

10

Visible and subvisible particles in the BCG immunotherapeutic product Immucyst®.

Kirkitadze M, Remi E, Bhandal K, Carpick B. Kirkitadze M, et al. Comput Struct Biotechnol J. 2016 Apr 6;14:154-60. doi: 10.1016/j.csbj.2016.03.001. eCollection 2016. Comput Struct Biotechnol J. 2016. PMID: 27158432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters